On 2 November 2026, Jinhai Medical Technology Limited (Jinhai Medical) executed a Strategic Cooperation Memorandum with Digital Health China Technologies Co., Ltd. (Digital Health), establishing a framework for collaboration in business operations and equity investments.
The memorandum permits both parties to investigate merger-and-acquisition prospects and equity participations by leveraging their respective strengths in resources, technology, marketing, and management. During the cooperation window—effective immediately and expiring on 31 March 2027—Jinhai Medical holds exclusive negotiation rights with Digital Health regarding the contemplated initiatives.
Key provisions include: • Scope: Joint assessment of potential M&A targets and equity investment projects within the medical technology and healthcare data sectors. • Governance: Any definitive transaction will be subject to separate legally binding agreements, standard due-diligence procedures, and internal approvals in compliance with applicable regulations. • Parties: Jinhai Medical, an HKEX-listed provider of minimally invasive surgery solutions, and Digital Health, a PRC-based specialist in medical big data and artificial intelligence.
The announcement underscores that the cooperation remains exploratory; therefore, shareholders and potential investors are advised to exercise caution when trading Jinhai Medical shares until further binding agreements are executed.
Comments